(Q34992783)

5 August 2017

1 reference

title

Management of malignant gastrointestinal stromal tumours (English)

1 reference

Christopher D. M. Fletcher

5 August 2017

author

2

object named as

Christopher Fletcher

1 reference

5 August 2017

4

Sandra Silberman

1 reference

5 August 2017

Heikki Joensuu

1

1 reference

5 August 2017

Sasa Dimitrijevic

3

1 reference

5 August 2017

Peter Roberts

5

1 reference

5 August 2017

George Demetri

6

1 reference

5 August 2017

publication date

1 November 2002

1 reference

Lancet Oncology Commission

5 August 2017

published in

1 reference

5 August 2017

volume

3

1 reference

5 August 2017

issue

11

1 reference

5 August 2017

page(s)

655-664

1 reference

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Diagnosis of gastrointestinal stromal tumors: A consensus approach

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Gastric stromal tumors. Reappraisal of histogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Familial gastrointestinal stromal tumours with germline mutation of the KIT gene

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Familial gastrointestinal stromal tumor with hyperpigmentation: association with a germline mutation of the c-kit gene

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Multiple small intestinal stromal tumors with skeinoid fibers in association with neurofibromatosis 1 (von Recklinghausen's disease).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Gastrointestinal stromal tumors: experience of an emergency surgery department

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Immunophenotype, proliferation, DNA ploidy, and biological behavior of gastrointestinal stromal tumors: a multivariate clinicopathologic study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Salvage surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Gastrointestinal stromal tumors: recent advances in understanding of their biology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Gastrointestinal autonomic nerve tumor: immunohistochemical and molecular identity with gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Gastrointestinal stromal tumors and KIT-positive mesenchymal cells in the omentum

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

CD34 immunoreactivity and interstitial cells of Cajal in the human and mouse gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Endosonographic differentiation of benign and malignant stromal cell tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Cytologic diagnosis of gastrointestinal stromal tumor with emphasis on the differential diagnosis with leiomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Gastric smooth muscle tumors: diagnostic dilemmas and factors affecting outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Smooth muscle tumors of the gastrointestinal tract: analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Primary gastrointestinal sarcomas: analysis of prognostic variables

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Sarcomas of the gastrointestinal tract. Separation into favorable and unfavorable prognostic groups by mitotic count

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

STAT protein recruitment and activation in c-Kit deletion mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Clinical management of gastrointestinal stromal tumors: before and after STI-571.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Surgery for disseminated abdominal sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Complete hepatic resection of metastases from leiomyosarcoma prolongs survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Tyrosine kinase inhibitor imatinib (STI571) as an anticancer agent for solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900899-9

7 January 2021

10.1016/S1470-2045(02)00899-9

Identifiers

DOI

1 reference

5 August 2017

1 reference